People on a high-dose regimen of the cholesterol drug Lipitor may have a slightly increased risk of developing type 2 diabetes — particularly if they have several of the classic diabetes risk factors, a study published Monday finds.
A number of studies have linked Lipitor (known generically as atorvastatin) and other cholesterol-lowering statin drugs to a small increase in users’ risk of diabetes.
This latest study, based on data from three large clinical trials, strengthens evidence of a connection.
But it also suggests that the risk may largely exist among people who also have the well-known risk factors for type 2 diabetes — including excess weight, high blood sugar, elevated triglycerides (a type of blood fat) and high blood pressure.
Those four factors appear “very good at distinguishing people at high or low risk for developing new-onset diabetes with atorvastatin,” lead researcher Dr. David D. Waters, of the University of California at San Francisco, told Reuters Health in an email.
If you are a woman who was were diagnosed with Diabetes while taking Lipitor, click here!
Latest posts by CitizensReport (see all)
- 4 Natural Alternatives To Energy Drinks That Will Make You Feel Healthier - July 19, 2017
- What A National Study Says About Blood Clot Filters - July 11, 2017
- Good Sugar, Bad Sugar: Why You Should Eat More Fruit - June 16, 2017